Related Posts
Chimeric Therapeutics (ASX:CHM) – bringing cell therapy to more patients with cancer, August 2021
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
Noosa Mining Investor Conference, July 2024 – Lake Resources (ASX:LKE)
25 Jul 2024 - Stuart Crow - Non Executive Chairman - Lake Resources N.L. (ASX:LKE, OTC: LLKKF) is a responsible lithium developer utilising state of-the-art ion exchange extraction technology for production of sustainable, high purity lithium from its flagship Kachi Project in Catamarca Province within the Lithium Triangle in Argentina. Lake also has three additional early-stage projects in this region.
Read More
Hazer Group (ASX:HZR) Commercial Develop ment Plant investment to proceed
03 Sep 2020 - Hazer Group (ASX:HZR) CEO & Managing Director, Geoff Ward talks about FY20 achievements, its final investment decision for its Commercial Development Plant to process low emissions hydrogen gas and high purity graphite production from biogas, development and commercial programs.
Read More
Fifty times more valuable than LNG: Searching for helium in Tanzania
17 May 2023 - Noble Helium Limited (ASX:NHE) Co-Founder and CEO Justyn Wood discusses the demand for and pricing of helium, the geology of the company's project in Tanzania, plans for helium transport and outlook.
Read More
icetana (ASX:ICE) discusses Macnica deal and new product launch
27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.
Read More
North Stawell Minerals (ASX:NSM) – exploring Victoria’s Golden Triangle
04 Sep 2023 - Scott Duncombe, Exploration Manager of North Stawell Minerals (ASX:NSM), provides an update on the company's gold exploration.
Read More
Inside Immutep’s latest trial readouts
14 July 2025 - Progress in cancer and autoimmune disease treatment
Read More
Synertec Corporation (ASX:SOP) FY19 results & outlook
03 Dec 2019 - Synertec Corporation Limited (ASX:SOP) Managing Director, Michael Carroll & CFO, David Harris talk FY19 results, market conditions and the outlook for specialist engineering and compliance services.
Read More
Lake Resources (ASX:LKE) announces two-phase production strategy for battery-grade lithium carbonate
22 Jun 2023 - Lake Resources Limited (ASX:LKE) Managing Director David Dickson discusses the company's two-phase strategy.
Read More
PainChek expanding into UK market
20 Mar 2024 - PainChek Limited (ASX:PCK) CEO Philip Daffas provides an overview of the company, discussing its recent agreement with Nourish Care to expand into the UK market.
Read More